CDMO industry in Europe
Latest cdmo industry news
Lonza Completes Expansion of Conjugation Facility in Visp, Switzerland
Expansion adds development and manufacturing capacity for pre-clinical, clinical and commercial supply of bioconjugates and antibody-drug conjugates. Additional manufacturing suites complement rece...
Lonza to Establish Large-Scale, Commercial Drug Product Fill & Finish Facility in Stein (CH)
Lonza will invest approximately CHF 500 million in the facility, fulfilling its strategic commitment to establish a commercial fill and finish offering that completes its full value chain
Arxada to Invest CHF 20m in its Industrial Biotechnology Plant in Kouřim, Czech Republic
This plant serves the contract development and manufacturing organization (CDMO) part of its Specialty Products Solutions business. This investment provides important infrastructure debottlenecking...
With a PIPS Complete subscription you get access to more data and advanced search and reporting tools.
Sign up at an attractive early subscriber price